Samuel Stanton, co-founder of Coefficient Bio, on the technical and business bets behind building an AI-native biotech, in conversation with Dimension Capital's Nan Li.
Recorded April 22, 2026 at UNLOCK 2026, a one-day AI x life sciences summit in San Francisco.
Speakers:
Samuel Stanton, Co-founder & Member of Technical Staff, Coefficient Bio
Nan Li, Co-founder & General Partner, Dimension Capital (moderator)
More from UNLOCK 2026:
Full playlist: • UNLOCK 2026: Sessions
Recap: unlockscience.ai/2026-recap
Hosted by Medra:
LinkedIn: / medra-ai
X: https://x.com/medra_ai
Follow for UNLOCK 2027:
LinkedIn: / unlock-ai-science
X: https://x.com/unlockscience26
#AI #LifeSciences #DrugDiscovery #UNLOCK2026